Physician profile
John Mostafa
NPI 1598058554
$12,920.24
in general payments reported to CMS, 2019-2025
25 companies · $223 in 2025
The $223 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,910 · 2020: $597 · 2021: $2,316 · 2022: $608 · 2023: $407 · 2024: $4,859 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,613 · Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,613.00 |
| Food and Beverage | $876.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $4,751.88 | 2024 | |
| Stryker Corporation | $2,708.53 | 2019-2025 | Actishield, Augment Injectable, 7 X 23mm Citrelock Implant |
| Novastep INC. | $2,602.47 | 2019-2021 | |
| Wright Medical Technology, INC. | $1,500.56 | 2019-2020 | |
| Extremity Medical | $172.58 | 2023 | Io Fix |
| Paratek Pharmaceuticals, INC. | $170.47 | 2023-2025 | Nuzyra |
| Tenex Health INC. | $158.35 | 2021 | |
| Paragon 28, INC. | $142.46 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $132.51 | 2019-2023 | Jublia |
| Medshape, INC. | $105.95 | 2023 | Dynanail, Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Zimmer Biomet Holdings, INC. | $59.51 | 2021 | |
| Integra Lifesciences Corporation | $51.46 | 2019-2021 | |
| Kerecis Limited | $50.37 | 2022 | |
| Linvatec Corporation | $48.35 | 2025 | Biobrace 23mm |
| Alexion Pharmaceuticals, INC. | $46.98 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $42.75 | 2019 | |
| Sebela Pharmaceuticals INC. | $35.77 | 2022-2023 | Naftin |
| Alfasigma USA, INC. | $26.63 | 2021 | |
| Depuy Synthes Sales INC. | $19.98 | 2022 | |
| Hydrofera LLC | $17.24 | 2022 | |
| Koya Medical, INC. | $17.13 | 2025 | Dayspring, Koya Medical |
| Pacira Pharmaceuticals Incorporated | $16.94 | 2025 | Exparel |
| Treace Medical Concepts, INC. | $14.97 | 2024 | |
| Merck Sharp & Dohme LLC | $14.04 | 2019 | |
| Sandoz INC. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mostafa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.